This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
這位Denali Therapeutics分析師以看好的基調開始覆蓋；以下是週五的主要啓動。
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
頂級華爾街分析師啓動了對這些頂尖公司的覆蓋。有關所有分析師評級變動的完整信息，包括上調、下調和啓動評級，請查看我們的分析師評級頁面。
- William Blair analyst Andy Hsieh initiated coverage on Elevation Oncology, Inc. (NASDAQ:ELEV) with an Outperform rating. Elevation Oncology shares closed at $0.5951 on Thursday. See how other analysts view this stock.
- William Blair analyst Sarah Schram initiated coverage on Denali Therapeutics Inc. (NASDAQ:DNLI) with an Outperform rating. Denali Therapeutics shares closed at $20.84 on Thursday. See how other analysts view this stock.
- 威廉·布萊爾分析師Andy Hsieh對Elevation Oncology, Inc.（納斯達克：ELEV）進行了覆蓋，給予了超越市場表現的評級。Elevation Oncology的股票在週四收盤價爲$0.5951。看看其他分析師如何看待這隻股票。
- 威廉·布萊爾分析師Sarah Schram對Denali Therapeutics Inc.（納斯達克：DNLI）進行了覆蓋，給予了超越市場表現的評級。Denali Therapeutics的股票在週四收盤價爲$20.84。看看其他分析師如何看待這隻股票。
Considering buying DNLI stock? Here's what analysts think:
考慮買入DNLI股票嗎？以下是分析師的看法：
Read This Next:
接下來請閱讀：
- How To Earn $500 A Month From KB Home Stock Ahead Of Q4 Earnings
- 如何在KB Home季度業績發佈前從KB Home股票中賺取每月500美元
資訊熱榜
更新時間